Impact BioMedical, Inc. (IBO)
0.489
+0.03
(+6.77%)
USD |
NYAM |
Sep 02, 16:00
0.489
0.00 (0.00%)
After-Hours: 16:51
Impact BioMedical Cash from Operations (Annual) : -1.89M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.89M |
| December 31, 2024 | -2.854M |
| December 31, 2023 | -2.851M |
| Date | Value |
|---|---|
| December 31, 2022 | -2.242M |
| December 31, 2021 | -2.027M |
| December 31, 2020 | -0.8985M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Enveric Biosciences, Inc. | -8.142M |
| LENZ Therapeutics, Inc. | -69.17M |
| ANI Pharmaceuticals, Inc. | 185.22M |
| Corcept Therapeutics, Inc. | 142.00M |
| Veru, Inc. | -30.04M |